Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001091818-21-000138
Filing Date
2021-10-28
Accepted
2021-10-28 13:05:37
Documents
35
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT bfnh10q0921.htm   iXBRL 10-Q 443261
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 4852
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 5057
4 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ex32-1.htm EX-32.1 2082
5 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 ex32-2.htm EX-32.2 2019
11 GRAPHIC bfnhlogo2019001.jpg GRAPHIC 27243
  Complete submission text file 0001091818-21-000138.txt   1602842

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bfnh-20210930.xsd EX-101.SCH 14295
7 XBRL CALCULATION FILE bfnh-20210930_cal.xml EX-101.CAL 15251
8 XBRL DEFINITION FILE bfnh-20210930_def.xml EX-101.DEF 25420
9 XBRL LABEL FILE bfnh-20210930_lab.xml EX-101.LAB 93450
10 XBRL PRESENTATION FILE bfnh-20210930_pre.xml EX-101.PRE 78879
12 EXTRACTED XBRL INSTANCE DOCUMENT bfnh10q0921_htm.xml XML 94287
Mailing Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454
Business Address 2020 GENERAL BOOTH BLVD SUITE 230 VIRGINIA BEACH VA 23454 757-306-6090
BIOFORCE NANOSCIENCES HOLDINGS, INC. (Filer) CIK: 0001310488 (see all company filings)

EIN.: 852138858 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51074 | Film No.: 211356713
SIC: 3826 Laboratory Analytical Instruments